Unveiling the non-canonical functions of EZH2 in prostate cancer is a research paper published in Oncotarget (2023). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA256741
NCI NIH HHS
Grant: P50 CA069568
NCI NIH HHS
Grant: R01 CA208257
NIGMS NIH HHS
Grant: R01 GM138407
NCI NIH HHS
Grant: P50 CA180995
NIGMS NIH HHS
Grant: R01 GM125632
National Institutes of Health
Grant: 5R01CA208257-06
The inhibitory network between EZH2 and PARP1 in triple-negative breast cancer
National Institutes of Health
Grant: 5P50CA180995-07
SPORE in Prostate Cancer
National Institutes of Health
Grant: 1R01CA256741-01A1
A non-canonical role for EZH2 in rRNA methtlation
FWCI
0.19
Citation Percentile
0.4%
Citation Trend
Fields of Study
MeSH Terms
Keywords